The further rescue experiments using Rac1 inhibitor NSC23766 treatment and AdRac1(G12V) infection verified the requirement of Rac1 and MEK1/2-ERK1/2 activation for DEF6-mediated pathological cardiac hypertrophy. This evidence concerns the gene MAP2K1 and cardiac hypertrophy.